James A. Szalony

445 total citations
10 papers, 372 citations indexed

About

James A. Szalony is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, James A. Szalony has authored 10 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in James A. Szalony's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Platelet Disorders and Treatments (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). James A. Szalony is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Platelet Disorders and Treatments (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). James A. Szalony collaborates with scholars based in United States, United Kingdom and Norway. James A. Szalony's co-authors include Nancy S. Nicholson, Anita K. Salyers, Susan G. Panzer‐Knodle, Larry P. Feigen, Jimmy D. Page, David M. Lansky, John J. Parlow, Michael S. South, Rhonda M. Lachance and Devan V. Mehrotra and has published in prestigious journals such as Circulation, Journal of Pharmacology and Experimental Therapeutics and American Heart Journal.

In The Last Decade

James A. Szalony

10 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Szalony United States 8 209 180 96 79 75 10 372
GG Nenci Italy 8 86 0.4× 137 0.8× 128 1.3× 17 0.2× 82 1.1× 18 328
Karsten Schrör Germany 4 112 0.5× 273 1.5× 131 1.4× 8 0.1× 86 1.1× 4 417
Gail Berman United States 6 132 0.6× 398 2.2× 131 1.4× 20 0.3× 124 1.7× 7 476
Khalid M. Naseem United Kingdom 11 136 0.7× 87 0.5× 55 0.6× 19 0.2× 21 0.3× 21 317
Н. А. Подоплелова Russia 11 213 1.0× 54 0.3× 19 0.2× 43 0.5× 25 0.3× 38 390
Marie-Blanche Onselaer United Kingdom 6 177 0.8× 124 0.7× 55 0.6× 10 0.1× 49 0.7× 8 310
Franck Lellouche France 8 194 0.9× 28 0.2× 25 0.3× 133 1.7× 9 0.1× 25 348
Frank C. Monkhouse Canada 9 106 0.5× 45 0.3× 64 0.7× 20 0.3× 32 0.4× 36 297
Christian Bischofs Germany 6 32 0.2× 229 1.3× 102 1.1× 5 0.1× 54 0.7× 8 329
Ohad S. Bentur United States 9 48 0.2× 78 0.4× 34 0.4× 10 0.1× 28 0.4× 27 214

Countries citing papers authored by James A. Szalony

Since Specialization
Citations

This map shows the geographic impact of James A. Szalony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Szalony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Szalony more than expected).

Fields of papers citing papers by James A. Szalony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Szalony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Szalony. The network helps show where James A. Szalony may publish in the future.

Co-authorship network of co-authors of James A. Szalony

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Szalony. A scholar is included among the top collaborators of James A. Szalony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Szalony. James A. Szalony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Szalony, James A., Anita K. Salyers, Susan G. Panzer‐Knodle, et al.. (2003). Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time. Thrombosis Research. 112(3). 167–174. 31 indexed citations
3.
Szalony, James A., Anita K. Salyers, Rhonda M. Lachance, et al.. (2003). Pharmacological Interruption of Acute Thrombus Formation with Minimal Hemorrhagic Complications by a Small Molecule Tissue Factor/Factor VIIa Inhibitor: Comparison to Factor Xa and Thrombin Inhibition in a Nonhuman Primate Thrombosis Model. Journal of Pharmacology and Experimental Therapeutics. 306(3). 1115–1121. 55 indexed citations
5.
Nicholson, Nancy S., Susan G. Panzer‐Knodle, Jimmy D. Page, et al.. (2001). Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist. Medicinal Research Reviews. 21(3). 211–226. 22 indexed citations
6.
Nicholson, Nancy S., Susan G. Panzer‐Knodle, James A. Szalony, et al.. (1998). Assessment of platelet function assays. American Heart Journal. 135(5). S170–S178. 127 indexed citations
7.
Szalony, James A., et al.. (1998). Protective Effect of Oral Xemilofiban in Arterial Thrombosis in Dogs. Circulation. 98(8). 813–820. 3 indexed citations
8.
Nicholson, Nancy S., Susan G. Panzer‐Knodle, Anita K. Salyers, et al.. (1995). SC-54684A: An Orally Active Inhibitor of Platelet Aggregation. Circulation. 91(2). 403–410. 56 indexed citations
9.
Szalony, James A., et al.. (1995). Extended Inhibition of Platelet Aggregation With the Orally Active Platelet Inhibitor SC-54684A. Circulation. 91(2). 411–416. 29 indexed citations
10.
Salyers, Anita K., et al.. (1994). A new method for measurement of plasma concentration of orally active glycoprotein IIb/IIIa antagonists. Thrombosis Research. 75(4). 409–417. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026